Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 49 non-cytoplasmic 50 69 transmembrane 70 80 cytoplasmic 81 101 transmembrane 102 106 non-cytoplasmic 107 130 transmembrane 131 141 cytoplasmic 142 162 transmembrane 163 173 non-cytoplasmic 174 196 transmembrane 197 239 cytoplasmic 240 262 transmembrane 263 273 non-cytoplasmic 274 297 transmembrane 298 308 cytoplasmic 309 327 transmembrane 328 332 non-cytoplasmic 333 352 transmembrane 353 361 cytoplasmic 362 385 transmembrane 386 396 non-cytoplasmic 397 417 transmembrane 418 431 cytoplasmic
Input: >PfGW456L13_3929 MKTLPAPLLAKISWRLLPFLLLMYIMAFLDRANVGFAKQAFQADTNISDAAFAFGAGVFF VGYALLEVPSNLILHRVGARLWMCRIMVTWGLVSAAMVFAHTETSFYILRFLLGVAEAGF FPGVILYLTYWFPSAVRGKAMGFFYFGAPLAFIFGSPLSGLLLELDGFAGFHGWQWLFAV EGLMATAVGIWAYWYLDNRPADAKWLTVEERQQVQSLLNQEDSHKQNHGRSLLNVICQPS VLYLCLIYLLIQASVYGVVFYLPSQVGGLLGTKVGLMVGLVTAIPWICALIAAYLIPGYS DRTGERRRTACLTLLMAAAGIACSVTFSNPLLGIIALCFAASGFIAVQPVFWTFPSSYLA GSAAAAGIALINSFGALGGFIAPVLKNWAEGAFHSPAAGLYVLAATTVIAALLVLGIRAP GHKASNKPATV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server